Annual EBIT:
-$301.54M+$190.96M(+38.77%)Summary
- As of today, ASND annual earnings before interest & taxes is -$301.54 million, with the most recent change of +$190.96 million (+38.77%) on December 31, 2024.
- During the last 3 years, ASND annual EBIT has risen by +$232.47 million (+43.53%).
- ASND annual EBIT is now -4402.42% below its all-time high of $7.01 million, reached on December 31, 2013.
Performance
ASND EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
-$60.06M+$49.62M(+45.24%)Summary
- As of today, ASND quarterly earnings before interest & taxes is -$60.06 million, with the most recent change of +$49.62 million (+45.24%) on June 1, 2025.
- Over the past year, ASND quarterly EBIT has increased by +$83.39 million (+58.13%).
- ASND quarterly EBIT is now -2034.42% below its all-time high of $3.10 million, reached on December 31, 2013.
Performance
ASND Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$275.61M+$83.39M(+23.23%)Summary
- As of today, ASND TTM earnings before interest & taxes is -$275.61 million, with the most recent change of +$83.39 million (+23.23%) on June 1, 2025.
- Over the past year, ASND TTM EBIT has increased by +$106.77 million (+27.92%).
- ASND TTM EBIT is now -5137.40% below its all-time high of $5.47 million, reached on December 31, 2013.
Performance
ASND TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ASND EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +38.8% | +58.1% | +27.9% |
| 3Y3 Years | +43.5% | +60.2% | +48.7% |
| 5Y5 Years | -18.8% | +34.3% | +17.9% |
ASND EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +48.9% | >-9999.0% | +61.0% | at high | +54.4% |
| 5Y | 5-Year | -18.8% | +48.9% | >-9999.0% | +61.0% | at high | +54.4% |
| All-Time | All-Time | -4402.4% | +48.9% | -2034.4% | +61.0% | -5137.4% | +54.4% |
ASND EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$60.06M(+45.2%) | -$275.61M(+23.2%) |
| Mar 2025 | - | -$109.68M(>-9900.0%) | -$359.00M(-18.6%) |
| Dec 2024 | -$301.54M(+38.8%) | $408.50K(+100.4%) | -$302.66M(+11.6%) |
| Sep 2024 | - | -$106.28M(+25.9%) | -$342.44M(+10.4%) |
| Jun 2024 | - | -$143.46M(-168.9%) | -$382.38M(+2.5%) |
| Mar 2024 | - | -$53.34M(-35.5%) | -$392.20M(+20.5%) |
| Dec 2023 | -$492.49M(+16.6%) | -$39.37M(+73.1%) | -$493.03M(+18.4%) |
| Sep 2023 | - | -$146.21M(+4.6%) | -$604.00M(-0.1%) |
| Jun 2023 | - | -$153.28M(+0.6%) | -$603.26M(-0.4%) |
| Mar 2023 | - | -$154.17M(-2.5%) | -$600.99M(-1.8%) |
| Dec 2022 | -$590.45M(-10.6%) | -$150.34M(-3.3%) | -$590.46M(-3.8%) |
| Sep 2022 | - | -$145.48M(+3.7%) | -$568.80M(-5.8%) |
| Jun 2022 | - | -$151.01M(-5.1%) | -$537.58M(-1.7%) |
| Mar 2022 | - | -$143.63M(-11.6%) | -$528.38M(+1.2%) |
| Dec 2021 | -$534.01M(-41.7%) | -$128.68M(-12.6%) | -$534.89M(-2.8%) |
| Sep 2021 | - | -$114.26M(+19.4%) | -$520.24M(-4.4%) |
| Jun 2021 | - | -$141.82M(+5.5%) | -$498.11M(-11.3%) |
| Mar 2021 | - | -$150.14M(-31.7%) | -$447.64M(-18.4%) |
| Dec 2020 | -$376.90M(-48.5%) | -$114.02M(-23.8%) | -$378.15M(-12.6%) |
| Sep 2020 | - | -$92.13M(-0.9%) | -$335.92M(-10.6%) |
| Jun 2020 | - | -$91.35M(-13.3%) | -$303.85M(-12.3%) |
| Mar 2020 | - | -$80.65M(-12.3%) | -$270.45M(-6.6%) |
| Dec 2019 | -$253.75M | -$71.80M(-19.5%) | -$253.71M(-13.9%) |
| Sep 2019 | - | -$60.06M(-3.6%) | -$222.82M(-7.5%) |
| Jun 2019 | - | -$57.95M(+9.3%) | -$207.30M(-1.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$63.91M(-56.2%) | -$203.47M(-11.3%) |
| Dec 2018 | -$182.57M(-45.1%) | -$40.91M(+8.1%) | -$182.79M(-1.9%) |
| Sep 2018 | - | -$44.53M(+17.7%) | -$179.37M(-4.4%) |
| Jun 2018 | - | -$54.12M(-25.2%) | -$171.80M(-18.6%) |
| Mar 2018 | - | -$43.23M(-15.3%) | -$144.85M(-14.3%) |
| Dec 2017 | -$125.81M(-56.0%) | -$37.49M(-1.4%) | -$126.74M(-11.9%) |
| Sep 2017 | - | -$36.97M(-36.1%) | -$113.21M(-17.5%) |
| Jun 2017 | - | -$27.17M(-8.2%) | -$96.31M(-12.2%) |
| Mar 2017 | - | -$25.11M(-4.8%) | -$85.87M(-6.7%) |
| Dec 2016 | -$80.66M(-73.9%) | -$23.96M(-19.4%) | -$80.48M(-12.0%) |
| Sep 2016 | - | -$20.07M(-20.0%) | -$71.85M(-19.9%) |
| Jun 2016 | - | -$16.72M(+15.2%) | -$59.92M(-4.4%) |
| Mar 2016 | - | -$19.73M(-28.7%) | -$57.40M(-52.4%) |
| Dec 2015 | -$46.38M(-191.7%) | -$15.33M(-88.5%) | -$37.67M(-20.9%) |
| Sep 2015 | - | -$8.13M(+42.8%) | -$31.16M(-19.9%) |
| Jun 2015 | - | -$14.21M(>-9900.0%) | -$25.99M(-120.5%) |
| Mar 2015 | - | $0.00(+100.0%) | -$11.79M(+5.5%) |
| Dec 2014 | -$15.90M(-326.9%) | -$8.82M(-197.5%) | -$12.47M(-2199.0%) |
| Sep 2014 | - | -$2.96M(>-9900.0%) | -$542.30K(-111.3%) |
| Jun 2014 | - | $0.00(+100.0%) | $4.79M(0.0%) |
| Mar 2014 | - | -$682.30K(-122.0%) | $4.79M(-12.5%) |
| Dec 2013 | $7.01M(+260.6%) | $3.10M(+31.2%) | $5.47M(+131.2%) |
| Sep 2013 | - | $2.37M(>+9900.0%) | $2.37M(>+9900.0%) |
| Jun 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2013 | - | $0.00 | $0.00 |
| Dec 2012 | $1.94M | - | - |
FAQ
- What is Ascendis Pharma A/S annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S annual EBIT year-on-year change?
- What is Ascendis Pharma A/S quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S quarterly EBIT year-on-year change?
- What is Ascendis Pharma A/S TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S TTM EBIT year-on-year change?
What is Ascendis Pharma A/S annual earnings before interest & taxes?
The current annual EBIT of ASND is -$301.54M
What is the all-time high annual EBIT for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high annual earnings before interest & taxes is $7.01M
What is Ascendis Pharma A/S annual EBIT year-on-year change?
Over the past year, ASND annual earnings before interest & taxes has changed by +$190.96M (+38.77%)
What is Ascendis Pharma A/S quarterly earnings before interest & taxes?
The current quarterly EBIT of ASND is -$60.06M
What is the all-time high quarterly EBIT for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high quarterly earnings before interest & taxes is $3.10M
What is Ascendis Pharma A/S quarterly EBIT year-on-year change?
Over the past year, ASND quarterly earnings before interest & taxes has changed by +$83.39M (+58.13%)
What is Ascendis Pharma A/S TTM earnings before interest & taxes?
The current TTM EBIT of ASND is -$275.61M
What is the all-time high TTM EBIT for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high TTM earnings before interest & taxes is $5.47M
What is Ascendis Pharma A/S TTM EBIT year-on-year change?
Over the past year, ASND TTM earnings before interest & taxes has changed by +$106.77M (+27.92%)